Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
CECO Environmental Corp. (CECO)
NASDAQIndustrialsIndustrial - Pollution & Treatment ControlsSnapshot 2026-11-04
$48.60-3.76%
Close 2026-11-02 · 1-day change
NASDAQIndustrialsIndustrial - Pollution & Treatment ControlsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.15 → 3.16 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CECO yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA grows 25% to $210 million in 2026 | Profit should rise with adjusted EBITDA near $210 million. | Broken | Adjusted EBITDA falls below $195 million in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is an acquisition-led growth story, not yet a proven durable compounder. The long-term thesis is supported by on-track integration and raised 2026 guidance, while the current thesis state is watch because recent financial performance trails its industry cohort.
CECO trades at a 1.44 premium versus peers, and its valuation rose recently. The model labels pricing as justified, with low fragility, but the negative expectations gap suggests market expectations may be demanding relative to the evidence; confidence in this reading is medium.
Near term, management reports Thermon integration and early cost savings ahead of plan, and first-half adjusted EBITDA grew 62% year over year. Full-year revenue and adjusted EBITDA guidance were raised, but earnings quality is assessed as fragile, recent performance as weak, and risk as elevated; a guidance cut after a recent increase would also damage credibility.
Over the next few quarters, the thesis depends on delivering the raised 2026 guidance and capturing at least $40 million in Thermon cost savings. Sector bellwethers VLTO, PCT, and ERII are another swing factor: continued strength could support the industrial backdrop, while misses or lower guidance could remove that support. The October notice concerning a listing-rule issue is an additional near-term concern, but the evidence does not explain its resolution.
For the 1-to-3-year view, CECO has meaningful growth and integration progress, but its premium valuation leaves limited room for weak execution, and recent relative performance warrants attention. The thesis hinges on sustained delivery and clearer evidence that the listing issue and earnings volatility are manageable. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The Thermon merger boosts sales and market reach. |
| Intact |
| Debt rises materially above $235 million or causes distress |
Debt $235M vs $235M target Merger closed June 2026 with $235M term loan; Q2 2026 earnings beat and raised guidance confirm no distress. Nov 2, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stable leadership and smooth integration of Thermon merger | The Thermon merger boosts sales and market reach. | Intact | Leadership turnover or merger integration problems arise | No leadership turnover or integration delays reported Merger completed, guidance raised, record Q2 sales, no negative leadership news. Nov 2, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows about 20% to $1.32 billion in 2026 | CECO aims to grow revenue 20% in 2026 to about $1.3 billion. | Intact | Revenue falls below $1.27 billion in FY26 | Revenue: $284.961M FY2026-Q2; GAAP. Published target: >= $1.32 billion. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 2026284,961,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.83 → $3.16 · observed estimates
$1.74B → $1.83B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-07-25 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-07-26 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-07-27 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-07-28 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-07-29 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-07-30 | $2.57 | $1,741,946,160 | 3 / 3 |
| 2026-07-31 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-08-01 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-08-02 | $2.83 | $1,741,896,340 | 4 / 5 |
| 2026-08-03 | $2.57 | $1,741,946,160 | 3 / 3 |
| 2026-08-04 | $2.57 | $1,741,946,160 | 3 / 3 |
| 2026-08-05 | $2.57 | $1,741,946,160 | 3 / 3 |
| 2026-08-06 | $2.57 | $1,741,946,160 | 3 / 3 |
| 2026-08-07 | $2.99 | $1,789,204,400 | 3 / 4 |
| 2026-08-08 | $2.99 | $1,789,161,530 | 6 / 7 |
| 2026-08-09 | $2.99 | $1,789,204,400 | 3 / 4 |
| 2026-08-10 | $2.99 | $1,789,204,400 | 3 / 4 |
| 2026-08-11 | $2.99 | $1,789,204,400 | 3 / 4 |
| 2026-08-12 | $2.99 | $1,789,204,400 | 3 / 4 |
| 2026-08-13 | $2.99 | $1,789,204,400 | 3 / 4 |
| 2026-08-14 | $2.99 | $1,789,204,400 | 3 / 4 |
| 2026-08-15 | $2.99 | $1,789,204,400 | 4 / 4 |
| 2026-08-16 | $2.99 | $1,789,204,400 | 4 / 4 |
| 2026-08-17 | $2.99 | $1,789,204,400 | 4 / 4 |
| 2026-08-18 | $2.99 | $1,789,204,400 | 4 / 4 |
| 2026-08-19 | $2.99 | $1,789,204,400 | 4 / 4 |
| 2026-08-20 | $3.09 | $1,816,857,143 | 4 / 4 |
| 2026-08-21 | $3.09 | $1,816,857,143 | 4 / 4 |
| 2026-08-22 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-23 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-24 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-25 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-26 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-27 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-28 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-29 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-30 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-08-31 | $3.09 | $1,816,877,944 | 4 / 4 |
| 2026-09-01 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-02 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-03 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-04 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-05 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-06 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-07 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-08 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-09 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-10 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-11 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-12 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-13 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-14 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-15 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-16 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-17 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-18 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-19 | $3.12 | $1,825,020,801 | 4 / 4 |
| 2026-09-20 | $3.14 | $1,846,307,601 | 4 / 4 |
| 2026-09-21 | $3.14 | $1,846,307,601 | 4 / 4 |
| 2026-09-22 | $3.14 | $1,846,307,601 | 4 / 4 |
| 2026-09-23 | $3.14 | $1,846,307,601 | 4 / 4 |
| 2026-09-24 | $3.14 | $1,846,307,601 | 4 / 4 |
| 2026-09-25 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-09-26 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-09-27 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-09-28 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-09-29 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-09-30 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-01 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-02 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-03 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-04 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-05 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-06 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-07 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-08 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-09 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-10 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-11 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-12 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-13 | $3.15 | $1,834,449,373 | 4 / 4 |
| 2026-10-14 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-15 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-16 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-17 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-18 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-19 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-20 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-21 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-22 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-23 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-24 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-25 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-26 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-27 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-28 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-29 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-30 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-10-31 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-11-01 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-11-02 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-11-03 | $3.16 | $1,834,666,655 | 4 / 4 |
| 2026-11-04 | $3.16 | $1,834,666,655 | 4 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.